XML 53 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 69,473 $ 17,076
Restricted cash 3,439 2,725
Accounts receivable, net 3,387 1,666
Inventory, net 17,070 23,260
Vendor deposits 7,161 4,789
Contract assets, current 6,386 1,859
Prepaid expenses 1,082 2,289
Grant receivable 3,256 263
Other receivables 7,500 0
Other current assets 3,577 1,220
Total current assets 122,331 55,147
Property, plant and equipment, net 37,855 27,169
Intangible assets, net 295 240
Goodwill 4,331 4,331
Operating lease right-of-use asset, net 4,033 4,316
Long-term restricted cash 11,755 11,422
Other assets, net 5,892 4,163
Total assets 186,492 106,788
Current liabilities:    
Accounts payable 20,540 34,669
Accrued expenses 32,332 15,359
Operating lease liability, current 1,496 1,106
Long-term debt, current 3,332 2,872
Convertible notes payable - related party 0 2,688
Contract liabilities, current 3,070 3,850
Other current liabilities 100 32
Total current liabilities 60,870 60,576
Long-term liabilities:    
Operating lease liability 3,350 4,130
Long-term debt 88,002 87,321
Convertible notes payable - related party 112,525 82,950
Contract liabilities, long-term 3,540 956
Warrants 27,461 78
Other liabilities 1,544 3,488
Total long-term liabilities 236,422 178,923
Total liabilities 297,292 239,499
COMMITMENTS AND CONTINGENCIES (NOTE 16)
SHAREHOLDERS' DEFICIT    
Common Stock, $0.0001 par value, 300,000,000 and 300,000,000 shares authorized, 199,133,827 and 82,653,781 shares outstanding at December 31, 2023 and 2022, respectively 21 9
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, no shares outstanding at December 31, 2023 and 2022 0 0
Additional paid in capital 765,018 513,614
Accumulated deficit (875,846) (646,340)
Accumulated other comprehensive income 7 6
Total shareholders' deficit (110,800) (132,711)
Total liabilities and shareholders’ deficit $ 186,492 $ 106,788